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Background: A modification to the Norwood procedure involving a right ventricle to pulmonary artery shunt (RV-PA) may improve early postoperative 
outcomes. Concerns remain about the effect of the RV-PA shunt and the accompanying ventriculotomy on long term ventricular function.
Methods: We compared 76 patients who underwent the Norwood procedure, from January 2000 through April 2005, with a modified Blalock-
Taussig shunt (mBT, n=35) versus RV-PA shunt (n=41). Patients were followed until death or September 1, 2009, with a median follow up of 5.5 
years. Cardiac catheterization, echocardiograms, perioperative Fontan courses, and need for cardiac transplantation were reviewed and compared 
between groups.
Results: Cumulative survival through the study period was 63% (22/35) in the mBT vs 78% (32/41) in the RV-PA group (P=0.14). Prior to Fontan 
procedure, ventricular function was worse in the RV-PA group. There was a trend towards the need for cardiac transplantation in the RV-PA group: 
6/32 (19%) vs 1/22 (5%) in the mBT group (P=0.06).Values are median (range), or mean ± SD. 
mBT (n=35) RV-PA (n=41) P value
Mortality 13 (37%) 9 (22%) 0.1
Norwood hospital death (n) 6 5 0.8
Pre-Stage 2 interstage death (n) 6 2 0.1
Stage 2 hospital death (n) 0 1 1.0
Pre-Fontan interstage death (n) 0 1 1.0
Fontan hospital death (n) 1 0 0.5
Transplanted or considering transplant 1/22 (5%) 10/32 (31%) 0.02
Considering transplant & delay Fontan (n) 0 4
Transplanted prior to Fontan (n) 1 4
Transplanted after Fontan (n) 0 2
Freedom from death or transplant 21 (60%) 26 (63%) 1.0
Pre-Fontan assessment (n=23) (n=32)
Echocardiography
Ventricular dysfunction 1(none)- 4(severe) 1 (1-2) 2 (1-4) 0.03
Tricuspid regurgitation 1(none)- 4(severe) 2 (1-4) 2 (1-4) 1.0
Cardiac catheterization
Mean atrial pressure (mmHg) 8 ± 5 8 ± 3 0.7
Mean pulmonary artery pressure (mmHg) 12 ± 4 12 ± 4 0.7
Ventricular end diastolic pressure (mmHg) 8 ± 3 8 ± 4 0.8
Transpulmonary gradient (mmHg) 4 ± 1 4 ± 2 0.8
Nakata index (mm2/m2) 272 ± 57 272 ± 69 1.0
Awaiting but anticipate Fontan (n) 4 3
Fontan hospitalization (n=18) (n=21)
Age (years) 3.7 ± 1.0 3.6 ± 1.1 1.0
Mechanical ventilation (hours) 25 (5-38) 19 (11-412) 0.2
Intensive care stay (days) 2.8 (1.8-11) 2 (1-27.8) 0.2
Hospital length of stay (days) 12 (7-44) 11 (8-38) 0.5
Conclusions: Neither shunt offers a clear survival advantage through the time period typical of Fontan completion. The RV-PA shunt results 
in impaired late ventricular function. Longer followup is necessary to determine whether placement of the RV-PA shunt at birth will result in an 
increased need for cardiac transplantation.
